Ligand Pharmaceuticals Incorporated (LGND) — Strategic Asset Allocation Index
Ligand Pharmaceuticals Incorporated (LGND) has a Strategic Asset Allocation Index of 31.4% as of March 2026. Strategic assets (PP&E of $- plus long-term investments of $312.82 Million) total $312.82 Million, measured against net assets of $997.32 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Ligand Pharmaceuticals Incorporated (LGND) balance sheet quality index to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Ligand Pharmaceuticals Incorporated Strategic Asset Allocation Index (2002–2025)
This chart shows how Ligand Pharmaceuticals Incorporated's Strategic Asset Allocation Index has evolved across 20 annual periods from 2002 to 2025. As of March 2026, the index stands at 31.4%, representing strategic assets of $312.82 Million against net assets of $997.32 Million USD. For live market cap and overall valuation, see LGND market cap.
Annual Strategic Asset Allocation Index for Ligand Pharmaceuticals Incorporated (2002–2025)
The table below presents the year-by-year Strategic Asset Allocation Index for Ligand Pharmaceuticals Incorporated from 2002 to 2025, covering 20 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See Ligand Pharmaceuticals Incorporated (LGND) net assets for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 35.9% | $364.83 Million | $- | $364.83 Million | $1.02 Billion | ▲ +12.3 pp |
| 2024 | 23.6% | $195.93 Million | $- | $195.93 Million | $830.44 Million | ▲ +16.7 pp |
| 2023 | 6.9% | $48.32 Million | $- | $48.32 Million | $700.91 Million | ▲ +1.8 pp |
| 2022 | 5.1% | $30.49 Million | $27.49 Million | $3.00 Million | $597.49 Million | ▲ +1.1 pp |
| 2021 | 4.0% | $32.75 Million | $32.75 Million | $- | $821.16 Million | ▲ +2.0 pp |
| 2020 | 2.0% | $14.43 Million | $14.43 Million | $- | $709.52 Million | ▲ +1.1 pp |
| 2019 | 0.9% | $7.18 Million | $7.18 Million | $- | $767.23 Million | ▼ 0.0 pp |
| 2018 | 1.0% | $5.37 Million | $5.37 Million | $0.00 | $560.91 Million | ▼ -1.6 pp |
| 2017 | 2.5% | $10.65 Million | $4.21 Million | $6.44 Million | $418.65 Million | ▼ -0.2 pp |
| 2016 | 2.7% | $10.16 Million | $1.82 Million | $8.35 Million | $370.85 Million | ▼ -7.1 pp |
| 2015 | 9.9% | $30.10 Million | $372.00K | $29.73 Million | $304.39 Million | ▼ -24.1 pp |
| 2014 | 33.9% | $8.28 Million | $867.00K | $7.42 Million | $24.41 Million | ▲ +32.2 pp |
| 2013 | 1.7% | $867.00K | $867.00K | $- | $49.61 Million | ▼ -32.2 pp |
| 2012 | 34.0% | $8.99 Million | $788.00K | $8.21 Million | $26.48 Million | ▲ +28.7 pp |
| 2011 | 5.3% | $455.00K | $455.00K | $- | $8.65 Million | ▼ -222.4 pp |
| 2009 | 227.6% | $8.52 Million | $8.52 Million | $- | $3.74 Million | ▲ +217.8 pp |
| 2007 | 9.8% | $2.87 Million | $2.87 Million | $- | $29.11 Million | ▼ -10.5 pp |
| 2006 | 20.3% | $5.55 Million | $5.55 Million | $- | $27.35 Million | ▼ -12.9 pp |
| 2003 | 33.2% | $23.50 Million | $23.50 Million | $- | $70.73 Million | ▲ +20.2 pp |
| 2002 | 13.1% | $9.67 Million | $9.67 Million | $- | $74.02 Million | — |